BIOIDENT Technologies (Menlo Park, CA, USA), a startup developer of printed semiconductor-based photonic lab-on-a-chip solutions for life sciences, has named Wasiq Bokhari as CEO and Max Sonnleitner as chief technology officer. Dr. Bokhari is a cofounder and managing partner of Quantum Insight and business advisor to Chevron and Hitachi in the areas of emerging life sciences, electronics and energy applications. Dr. Sonnleitner was most recently vice president, R&D life science for NANOIDENT, BIOIDENT's Vienna-based parent company.
Inflazyme Pharmaceuticals (Vancouver, BC, Canada) has announced the appointment of Jeremy Curnock Cook as chairman of the board of directors, succeeding John Hodgman, who has resigned his position because of increased commitments resulting from his recent appointment as senior vice president and CFO at InterMune. Mr. Curnock Cook is currently the executive chairman of Bioscience Managers Ltd., a corporate and investment advisory company based in London. He has been an independent director at Inflazyme since 1997.
This is a preview of subscription content, access via your institution
